More and more patients are discussing Wegovy and other GLP-1 medications due to their observed impact in body composition changes. First developed to treat blood sugar issues, these GLP-1 receptor agonists operate by imitating a inherent compound that influences appetite and reduces gastric motility . This combined effect can result in noticeable